Zosano Pharma Corp Investing Cash Flow
Zosano Pharma Corp reported Investing Cash Flow of -$65.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2022-05-13
- Zosano Pharma Corp net cash provided by (used in) investing activities for the quarter ending 2022-03-31 was -$65.00K.
- Zosano Pharma Corp net cash provided by (used in) investing activities for the quarter ending 2021-12-31 was -$408.00K.
- Zosano Pharma Corp net cash provided by (used in) investing activities for the quarter ending 2021-09-30 was -$592.00K.
- Zosano Pharma Corp net cash provided by (used in) investing activities for the quarter ending 2021-06-30 was -$1.19M.
- Zosano Pharma Corp net cash provided by (used in) investing activities for fiscal 2021 was -$5.42M.
- Zosano Pharma Corp net cash provided by (used in) investing activities for fiscal 2020 was -$8.49M, a 492.19% decline from fiscal 2019.
- Zosano Pharma Corp net cash provided by (used in) investing activities for fiscal 2019 was $2.16M.
- Zosano Pharma Corp net cash provided by (used in) investing activities for fiscal 2018 was -$19.21M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$65.00K 10-Q · filed 2022-05-13 | -$473.00K derived: sum of 2 quarters · filed 2022-05-13 | -$1.06M derived: sum of 3 quarters · filed 2022-05-13 | -$2.25M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | -$408.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$1.00M derived: sum of 2 quarters · filed 2022-03-17 | -$2.19M derived: sum of 3 quarters · filed 2022-03-17 | -$5.42M 10-K · filed 2022-03-17 |
| 2021-09-30 | -$592.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$1.78M derived: sum of 2 quarters · filed 2021-11-10 | -$5.01M 10-Q · filed 2021-11-10 | -$5.79M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | -$1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$4.42M 10-Q · filed 2021-08-10 | -$5.20M derived: sum of 3 quarters · filed 2022-05-13 | -$8.20M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | -$3.24M 10-Q · filed 2022-05-13 | -$4.01M derived: sum of 2 quarters · filed 2022-05-13 | -$7.02M derived: sum of 3 quarters · filed 2022-05-13 | -$10.34M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$776.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$3.78M derived: sum of 2 quarters · filed 2022-03-17 | -$7.10M derived: sum of 3 quarters · filed 2022-03-17 | -$8.49M 10-K · filed 2022-03-17 |
| 2020-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$6.33M derived: sum of 2 quarters · filed 2021-11-10 | -$7.71M 10-Q · filed 2021-11-10 | -$8.53M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$3.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$4.71M 10-Q · filed 2021-08-10 | -$5.53M derived: sum of 3 quarters · filed 2021-08-10 | -$6.75M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$1.38M 10-Q · filed 2021-05-12 | -$2.21M derived: sum of 2 quarters · filed 2021-05-12 | -$3.43M derived: sum of 3 quarters · filed 2021-05-12 | -$4.20M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$821.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$2.05M derived: sum of 2 quarters · filed 2021-03-11 | -$2.82M derived: sum of 3 quarters · filed 2021-03-11 | $2.16M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$2.00M derived: sum of 2 quarters · filed 2020-11-13 | $2.98M 10-Q · filed 2020-11-13 | $5.30M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | -$773.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $4.21M 10-Q · filed 2020-08-06 | $6.53M derived: sum of 3 quarters · filed 2020-08-06 | $8.58M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $4.98M 10-Q · filed 2020-05-14 | $7.30M derived: sum of 2 quarters · filed 2020-05-14 | $9.35M derived: sum of 3 quarters · filed 2020-05-14 | |
| 2018-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $4.37M derived: sum of 2 quarters · filed 2020-03-13 | -$19.21M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$21.53M 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | -$23.58M 10-Q · filed 2018-08-09 | |||
| 2017-09-30 | $427.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-15 | -$7.25M 10-Q · filed 2018-11-15 | ||
| 2017-06-30 | -$7.67M 10-Q · filed 2018-08-09 |